These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 5703695

  • 1. Therapeutic effects of ambilhar (niridazole) in children and adults with Schistosoma mansoni infection.
    Jarumilinta R, Ruas A, Lambert CR.
    Ann Trop Med Parasitol; 1968 Jun; 62(2):154-7. PubMed ID: 5703695
    [No Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of niridazole in Schistosoma haematobium and mansoni infections.
    Abdallah A, Saif M.
    Ann N Y Acad Sci; 1969 Oct 06; 160(2):686-95. PubMed ID: 4898961
    [No Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of niridazole in Schistosoma mansoni infections.
    Prata A.
    Ann N Y Acad Sci; 1969 Oct 06; 160(2):660-9. PubMed ID: 5259286
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of schistosomiasis japonica with niridazole.
    Yokogawa M, Sano M, Tsuji M, Kojima S, Iijima T, Ito Y.
    Ann N Y Acad Sci; 1969 Oct 06; 160(2):933-46. PubMed ID: 4390500
    [No Abstract] [Full Text] [Related]

  • 5. Some observations on the use of niridazole (Ciba 32,644-Ba, Ambilhar) in the treatment of Schistosoma mansoni infections in Mwanza, Tanzania.
    Eyakuze VM.
    East Afr Med J; 1968 Mar 06; 45(3):147-52. PubMed ID: 5658192
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of hepatosplenic schistosomiasis mansoni with niridazole: relationships among liver function, effective dose, and side effects.
    Coutinho A, Barreto FT.
    Ann N Y Acad Sci; 1969 Oct 06; 160(2):612-28. PubMed ID: 5259282
    [No Abstract] [Full Text] [Related]

  • 7. The effects of niridazole in experimental schistosomiasis.
    Striebel HP.
    Ann N Y Acad Sci; 1969 Oct 06; 160(2):491-518. PubMed ID: 4981049
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risks versus benefits in antischistosomal therapy.
    Fontanilles F.
    Ann N Y Acad Sci; 1969 Oct 06; 160(2):811-20. PubMed ID: 5259299
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Schistosomiasis mansoni therapy with a new nitrothiazole derivative].
    de Almeida Júnior N.
    Rev Bras Med; 1967 Jun 06; 24(6):447-52. PubMed ID: 5605801
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of schistosomiasis mansoni by the combination of ambilhar and barbiturate. Preliminary note on its tolerability].
    Zacharias N, Carvalho PR, Penteado JF.
    Hospital (Rio J); 1967 Mar 06; 71(3):657-62. PubMed ID: 5304371
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dosage schemes and dosage response of niridazole in schistosomiasis.
    Clarke Vde V, Blair DM.
    Ann N Y Acad Sci; 1969 Oct 06; 160(2):645-9. PubMed ID: 5259284
    [No Abstract] [Full Text] [Related]

  • 20. Further observations on the use of ambilhar in the treatment of schistosomiasis mansoni in the Sudan.
    Abdalla RE, Iskander S, Haseeb MA.
    J Trop Med Hyg; 1968 Feb 06; 71(2):44-5. PubMed ID: 5639810
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.